Cargando…
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
PURPOSE: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomica...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863788/ https://www.ncbi.nlm.nih.gov/pubmed/31664501 http://dx.doi.org/10.1007/s00134-019-05819-3 |
_version_ | 1783471761942118400 |
---|---|
author | Blot, Stijn Antonelli, Massimo Arvaniti, Kostoula Blot, Koen Creagh-Brown, Ben de Lange, Dylan De Waele, Jan Deschepper, Mieke Dikmen, Yalim Dimopoulos, George Eckmann, Christian Francois, Guy Girardis, Massimo Koulenti, Despoina Labeau, Sonia Lipman, Jeffrey Lipovestky, Fernando Maseda, Emilio Montravers, Philippe Mikstacki, Adam Paiva, José-Artur Pereyra, Cecilia Rello, Jordi Timsit, Jean-Francois Vogelaers, Dirk |
author_facet | Blot, Stijn Antonelli, Massimo Arvaniti, Kostoula Blot, Koen Creagh-Brown, Ben de Lange, Dylan De Waele, Jan Deschepper, Mieke Dikmen, Yalim Dimopoulos, George Eckmann, Christian Francois, Guy Girardis, Massimo Koulenti, Despoina Labeau, Sonia Lipman, Jeffrey Lipovestky, Fernando Maseda, Emilio Montravers, Philippe Mikstacki, Adam Paiva, José-Artur Pereyra, Cecilia Rello, Jordi Timsit, Jean-Francois Vogelaers, Dirk |
author_sort | Blot, Stijn |
collection | PubMed |
description | PURPOSE: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomical disruption (absent or present with localized or diffuse peritonitis), and severity of disease expression (infection, sepsis, and septic shock). METHODS: We performed a multicenter (n = 309), observational, epidemiological study including adult ICU patients diagnosed with intra-abdominal infection. Risk factors for mortality were assessed by logistic regression analysis. RESULTS: The cohort included 2621 patients. Setting of infection acquisition was community-acquired in 31.6%, early onset hospital-acquired in 25%, and late-onset hospital-acquired in 43.4% of patients. Overall prevalence of antimicrobial resistance was 26.3% and difficult-to-treat resistant Gram-negative bacteria 4.3%, with great variation according to geographic region. No difference in prevalence of antimicrobial resistance was observed according to setting of infection acquisition. Overall mortality was 29.1%. Independent risk factors for mortality included late-onset hospital-acquired infection, diffuse peritonitis, sepsis, septic shock, older age, malnutrition, liver failure, congestive heart failure, antimicrobial resistance (either methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Gram-negative bacteria, or carbapenem-resistant Gram-negative bacteria) and source control failure evidenced by either the need for surgical revision or persistent inflammation. CONCLUSION: This multinational, heterogeneous cohort of ICU patients with intra-abdominal infection revealed that setting of infection acquisition, anatomical disruption, and severity of disease expression are disease-specific phenotypic characteristics associated with outcome, irrespective of the type of infection. Antimicrobial resistance is equally common in community-acquired as in hospital-acquired infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-019-05819-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6863788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-68637882019-12-05 Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project Blot, Stijn Antonelli, Massimo Arvaniti, Kostoula Blot, Koen Creagh-Brown, Ben de Lange, Dylan De Waele, Jan Deschepper, Mieke Dikmen, Yalim Dimopoulos, George Eckmann, Christian Francois, Guy Girardis, Massimo Koulenti, Despoina Labeau, Sonia Lipman, Jeffrey Lipovestky, Fernando Maseda, Emilio Montravers, Philippe Mikstacki, Adam Paiva, José-Artur Pereyra, Cecilia Rello, Jordi Timsit, Jean-Francois Vogelaers, Dirk Intensive Care Med Original PURPOSE: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomical disruption (absent or present with localized or diffuse peritonitis), and severity of disease expression (infection, sepsis, and septic shock). METHODS: We performed a multicenter (n = 309), observational, epidemiological study including adult ICU patients diagnosed with intra-abdominal infection. Risk factors for mortality were assessed by logistic regression analysis. RESULTS: The cohort included 2621 patients. Setting of infection acquisition was community-acquired in 31.6%, early onset hospital-acquired in 25%, and late-onset hospital-acquired in 43.4% of patients. Overall prevalence of antimicrobial resistance was 26.3% and difficult-to-treat resistant Gram-negative bacteria 4.3%, with great variation according to geographic region. No difference in prevalence of antimicrobial resistance was observed according to setting of infection acquisition. Overall mortality was 29.1%. Independent risk factors for mortality included late-onset hospital-acquired infection, diffuse peritonitis, sepsis, septic shock, older age, malnutrition, liver failure, congestive heart failure, antimicrobial resistance (either methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Gram-negative bacteria, or carbapenem-resistant Gram-negative bacteria) and source control failure evidenced by either the need for surgical revision or persistent inflammation. CONCLUSION: This multinational, heterogeneous cohort of ICU patients with intra-abdominal infection revealed that setting of infection acquisition, anatomical disruption, and severity of disease expression are disease-specific phenotypic characteristics associated with outcome, irrespective of the type of infection. Antimicrobial resistance is equally common in community-acquired as in hospital-acquired infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-019-05819-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-10-29 2019 /pmc/articles/PMC6863788/ /pubmed/31664501 http://dx.doi.org/10.1007/s00134-019-05819-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Blot, Stijn Antonelli, Massimo Arvaniti, Kostoula Blot, Koen Creagh-Brown, Ben de Lange, Dylan De Waele, Jan Deschepper, Mieke Dikmen, Yalim Dimopoulos, George Eckmann, Christian Francois, Guy Girardis, Massimo Koulenti, Despoina Labeau, Sonia Lipman, Jeffrey Lipovestky, Fernando Maseda, Emilio Montravers, Philippe Mikstacki, Adam Paiva, José-Artur Pereyra, Cecilia Rello, Jordi Timsit, Jean-Francois Vogelaers, Dirk Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project |
title | Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project |
title_full | Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project |
title_fullStr | Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project |
title_full_unstemmed | Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project |
title_short | Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project |
title_sort | epidemiology of intra-abdominal infection and sepsis in critically ill patients: “abses”, a multinational observational cohort study and esicm trials group project |
topic | Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863788/ https://www.ncbi.nlm.nih.gov/pubmed/31664501 http://dx.doi.org/10.1007/s00134-019-05819-3 |
work_keys_str_mv | AT blotstijn epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT antonellimassimo epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT arvanitikostoula epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT blotkoen epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT creaghbrownben epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT delangedylan epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT dewaelejan epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT descheppermieke epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT dikmenyalim epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT dimopoulosgeorge epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT eckmannchristian epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT francoisguy epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT girardismassimo epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT koulentidespoina epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT labeausonia epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT lipmanjeffrey epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT lipovestkyfernando epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT masedaemilio epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT montraversphilippe epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT mikstackiadam epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT paivajoseartur epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT pereyracecilia epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT rellojordi epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT timsitjeanfrancois epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT vogelaersdirk epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject AT epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject |